SDC1 and plasma cell myeloma: The CD138+ cell enrichment procedure itself had no effect on the (phospho)proteome of malignant plasma cells as assessed in the myeloma cell line MM.1S (Extended Data Fig. 1i and Supplementary Tables 4 and 5).